January 30, 2023
Kristy Ainslie, Ph.D., has been named the recipient of the 2023 Sato Memorial International Award. The Sato Memorial fund presents this award to a person who has greatly contributed to the fields of pharmacology, therapeutics and pharmaceutical sciences in the United States.
The Sato memorial fund was created to encourage innovation in pharmaceutical science research through the exchange of scientists between Japan and the United States. Keeping in line with this vision, Ainslie will travel to Sapporo, Japan in March to receive this award at the 143rd Annual Meeting of the Pharmaceutical Society of Japan.
“It’s really an incredible honor to receive such a notable award as the Sato Memorial International Award and I thank the Pharmaceutical Society of Japan for recognizing me in that way,” said Ainslie. “It is humbling to be included with the past recipients and to have my research highlighted among their achievements in pharmaceutical sciences.”
Ainslie is a Fred Eshelman Distinguished Professor in pharmaceutical science at the UNC Eshelman School of Pharmacy and chair of the Division of Pharmacoengineering and Molecular Pharmaceutics. Ainslie uses her knowledge of biomaterials and immunology to develop new immune-modulatory therapies that treat and prevent infectious and autoimmune diseases.
Ainslie’s current projects include formulating polymers for a universal influenza vaccine, discovering small molecule host directed therapies for treatment of multi-drug resistant infections, fabricating nanofibrous scaffolds for treatment of glioblastoma, and engineering antigen specific therapies to treat autoimmune diseases such as multiple sclerosis and type 1 diabetes.
Latest News
More work must be done to reduce acetaminophen hepatotoxicity
